These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39148792)

  • 41. A salicylaldehyde benzoyl hydrazone based near-infrared probe for copper(ii) and its bioimaging applications.
    Zhao J; Wang YY; Chen WL; Hao GS; Sun JP; Shi QF; Tian F; Ma RT
    RSC Adv; 2022 Jan; 12(5):3073-3080. PubMed ID: 35425318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of Cu chemical state inside single neurons from Parkinson's disease and control substantia nigra using the micro-XANES technique.
    Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Bohic S; Lankosz M
    J Trace Elem Med Biol; 2008; 22(3):183-8. PubMed ID: 18755393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel near-infrared fluorescent platform with good photostability and the application for a reaction-based Cu(2+) probe in living cells.
    Liu K; Shang H; Meng F; Liu Y; Lin W
    Talanta; 2016 Jan; 147():193-8. PubMed ID: 26592595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of Baicalin on the expression of connexin 36 in the cerebral cortex and striatum area of Parkinson's disease model rat].
    Halida B; Yao YN; Han XJ; Yang XL
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):218-222. PubMed ID: 30669767
    [No Abstract]   [Full Text] [Related]  

  • 45. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for
    Fang D; Wen X; Wang Y; Sun Y; An R; Zhou Y; Ye D; Liu H
    Theranostics; 2022; 12(7):3178-3195. PubMed ID: 35547754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).
    Matusch A; Depboylu C; Palm C; Wu B; Höglinger GU; Schäfer MK; Becker JS
    J Am Soc Mass Spectrom; 2010 Jan; 21(1):161-71. PubMed ID: 19892565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoplasmic reticulum-targeted polymer dots encapsulated with ultrasonic synthesized near-infrared carbon nanodots and their application for in vivo monitoring of Cu
    Huang H; Li S; Chen B; Wang Y; Shen Z; Qiu M; Pan H; Wang W; Wang Y; Li X
    J Colloid Interface Sci; 2022 Dec; 627():705-715. PubMed ID: 35878461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of alpha-synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo.
    Lee EJ; Aguirre-Padilla DH; Fomenko A; Pawar G; Kapadia M; George J; Lozano AM; Hamani C; Kalia LV; Kalia SK
    Brain Stimul; 2024; 17(2):166-175. PubMed ID: 38342364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.
    Khairnar A; Latta P; Drazanova E; Ruda-Kucerova J; Szabó N; Arab A; Hutter-Paier B; Havas D; Windisch M; Sulcova A; Starcuk Z; Rektorova I
    Neurotox Res; 2015 Nov; 28(4):281-9. PubMed ID: 26153486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tracking Innate Immune Activation in a Mouse Model of Parkinson's Disease Using TREM1 and TSPO PET Tracers.
    Lucot KL; Stevens MY; Bonham TA; Azevedo EC; Chaney AM; Webber ED; Jain P; Klockow JL; Jackson IM; Carlson ML; Graves EE; Montine TJ; James ML
    J Nucl Med; 2022 Oct; 63(10):1570-1578. PubMed ID: 35177426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease.
    Gou DH; Huang TT; Li W; Gao XD; Haikal C; Wang XH; Song DY; Liang X; Zhu L; Tang Y; Ding C; Li JY
    Redox Biol; 2021 Jan; 38():101795. PubMed ID: 33232911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visualization of cysteine in AD mouse with a high-quantum yield NIR fluorescent probe.
    Zhou Z; Fang C; Yu F; Shen Y; Xu H; Li H; Zhang Y
    Talanta; 2024 Oct; 278():126482. PubMed ID: 38950502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amelioration of Motor Performance and Nigrostriatal Dopamine Cell Volume Using a Novel Far-Infrared Ceramic Blanket in an A53T Alpha-Synuclein Transgenic Parkinson's Disease Mouse Model.
    Carrick FR; Hernandez LSAV; Sugaya K
    Curr Issues Mol Biol; 2023 Dec; 45(12):9823-9837. PubMed ID: 38132459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between Heavy Metal Exposure and Parkinson's Disease: A Review of the Mechanisms Related to Oxidative Stress.
    Pyatha S; Kim H; Lee D; Kim K
    Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.